Literature DB >> 21218511

Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.

J-S Wang1, S-T Tu, I-T Lee, S-D Lin, S-Y Lin, S-L Su, W-J Lee, Wayne H-H Sheu.   

Abstract

BACKGROUND: previous studies examining the contributions of fasting glucose (FG) and postprandial glucose (PPG) to glycated haemoglobin (HbA(1c)) have yielded conflicting results. We aimed to clarify the contributions of PPG to hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.
METHODS: continuous glucose monitoring was conducted in 121 non-insulin-using type 2 diabetic outpatients, who were divided into five groups according to quintiles of HbA(1c) (ranging from 5.7 to 12.7%). Glucose area under the curve (AUC) above a glucose value of 5.5 mmol/L 24 or 4 h after meals was defined as AUC(total). Glucose AUC above FG or preprandial glucose levels was defined as AUC(PPG). The contribution of PPG to hyperglycaemia was calculated as (AUC(PPG)/AUC(total) × 100%. The contribution of FG or preprandial glucose was calculated as [(AUC(total) - AUC(PPG))/AUC(total)] × 100%.
RESULTS: the contribution of PPG to either 24-h hyperglycaemia or 4-h hyperglycaemia after meals was significantly higher than FG and preprandial glucose in the lowest quintile of HbA(1c) (both p < 0.001). However, no difference was observed in the other four quintiles. Peak PPG and glucose excursions were higher after breakfast than those after lunch and dinner (p < 0.01 for all comparisons).
CONCLUSIONS: in Asian patients with type 2 diabetes, PPG 24 and 4 h after meals was a predominant contributor to excess hyperglycaemia in well-controlled patients and was equally important as FG or preprandial glucose in moderately to poorly controlled patients with mean HbA(1c) up to 10%. 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21218511     DOI: 10.1002/dmrr.1149

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  43 in total

1.  6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.

Authors:  Aus Alzaid; Christof Schlaeger; Rolf Hinzmann
Journal:  Diabetes Technol Ther       Date:  2013-09-28       Impact factor: 6.118

2.  A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.

Authors:  Weiwei Zhang; Dongjun Kim; Elizabeth Philip; Zahid Miyan; Irina Barykina; Birgit Schmidt; Herbert Stein
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

3.  Contributions of Basal Glucose and Postprandial Glucose Concentrations to Hemoglobin A1c in the Newly Diagnosed Patients with Type 2 Diabetes--the Preliminary Study.

Authors:  Xin Kang; Chun Wang; Dawei Chen; Lifang Lv; Guanjian Liu; Jie Xiao; Yanzhi Yang; Liping He; Lihong Chen; Xiujun Li; Haoming Tian; Weiping Jia; Xingwu Ran
Journal:  Diabetes Technol Ther       Date:  2015-03-31       Impact factor: 6.118

Review 4.  The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia.

Authors:  Ju-Ming Lu
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

5.  Glucose metabolism before and after radioiodine therapy of a patient with Graves' disease: Assessment by continuous glucose monitoring.

Authors:  Yun Hu; Gu Gao; Reng-Na Yan; Feng-Fei Li; Xiao-Fei Su; Jian-Hua Ma
Journal:  Biomed Rep       Date:  2017-06-21

Review 6.  Transculturalization of a diabetes-specific nutrition algorithm: Asian application.

Authors:  Hsiu-Yueh Su; Man-Wo Tsang; Shih-Yi Huang; Jeffrey I Mechanick; Wayne H-H Sheu; Albert Marchetti
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

7.  Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes.

Authors:  Matthew Riddle; Guillermo Umpierrez; Andres DiGenio; Rong Zhou; Julio Rosenstock
Journal:  Diabetes Care       Date:  2011-10-25       Impact factor: 19.112

8.  Insulin initiation: bringing objectivity to choice.

Authors:  Sanjay Kalra; Yashdeep Gupta
Journal:  J Diabetes Metab Disord       Date:  2015-03-25

Review 9.  Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus.

Authors:  Rajeev Chawla; Jagat Jyoti Mukherjee; Manoj Chawla; Alok Kanungo; Meenakshi Sundaram Shunmugavelu; Ashok Kumar Das
Journal:  Med Sci (Basel)       Date:  2021-05-28

10.  Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients.

Authors:  Ting Wang; Wei Yin; Yonghan Huang; Qingxue Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-10       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.